Skip to main content
. Author manuscript; available in PMC: 2019 Aug 8.
Published in final edited form as: Stem Cell Res. 2019 May 15;38:101461. doi: 10.1016/j.scr.2019.101461
Unique stem cell line identifier TRNDi009-C
Alternative name(s) of stem cell line HT220C
Institution National Institutes of Health
National Center for Advancing Translational Sciences
Bethesda, Maryland, USA
Contact information of distributor Dr. Wei Zheng; Wei.Zheng@nih.gov
Type of cell line iPSC
Origin Human
Additional origin info Age: 21-fetal-week-old
Sex: Female
Ethnicity: Caucasian
Cell Source Fibroblasts
Clonality Clonal
Method of reprogramming Integration-free Sendai viral vectors
Genetic Modification NO
Type of Modification N/A
Associated disease Niemann-Pick disease Type A (NPA)
Gene/locus Gene: SMPD1
Locus: 11p15.4
Mutation: p. L302P (c.905 T > C)
Method of modification N/A
Name of transgene or resistance N/A
Inducible/constitutive system N/A
Date archived/stock date 2018
Cell line repository/bank N/A
Ethical approval NIGMS Informed Consent Form was obtained from patient at time of sample submission. Confidentiality Certificate: CC-GM-15–004